Answers are grounded in this paper and cite their sources.
The validated analytical method accurately estimates semaglutide in pharmaceutical forms, highlighting robustness in testing.
An efficient and simple RP-HPLC method has been developed and validated for the estimation of Semaglutide in bulk and marketed pharmaceutical dosage forms. The mobile phase used for the chromatographic runs consisted of Methanol and Phosphate buffer (0.02M, pH-3.6)in the ratio of 40:76% v/v. The separation was achieved on anInertsil C18 ODS (4.6mm×250mm) 5µm particle size column using isocratic mode. Drug peak were well separated and were detected by a UV detector at 246 nm. The method was linear at the concentration range 6–14 μg/ml for Semaglutide. The method has been validated according to ICH guidelines with respect to system suitability, specificity, precision, accuracy and robustness. Semaglutide limit of detection (LOD) and limit of quantification (LOQ) were 0.487μg/ml and 1.477μg/ml respectively.
No takes yet. Share an insight, caveat, or question.
Satpathy et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: